OVER THE COUNTER DRUGS MARKET ANALYSIS

Over the Counter Drugs Market, By Product Type (Cough, Cold, and Flu Products, Analgesics, Dermatology Products, Gastrointestinal Products, Vitamins, Mineral, and Supplements (VMS), Weight-loss/Dietary Products, Ophthalmic Products, Sleeping Aids, and Other Product Types), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacy, and Other Distribution Channels), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Published In : Sep 2022
Code : CMI1218
Pages :165
Formats :
Excel and PDF
Industry : Pharmaceutical

Market News

Global Over the Counter Drugs Market: Key Developments

In January 2020, Sanofi acquired Synthorx Inc. It is a clinical-stage biotechnology company focused upon improving the lives of people with cancer and autoimmune disorders.

In September 2019, L'Oreal launched its new over-the-counter product AcneFree (Adapalene Gel) a topical retinoid treatment for acne-prone skin.

In August 2019, Bayer and BlueRock Therapeutics signed an agreement under which Bayer will fully acquire BlueRock, a biotechnology company focused on developing engineered cell therapies in the fields of neurology, cardiology, and immunology, using a proprietary induced pluripotent stem cell (iPSC) platform.

In July 2019, Sanofi and Roche signed an agreement for the exclusive over-the-counter (OTC) rights to Tamiflu to prevent and treat influenza or flu in the United States.

In April 2019, Johnson & Johnson acquired Auris Health Inc., which advances its commitment to combating lung cancer and expands its digital surgery portfolio across surgical specialties.